Exagen Inc (XGN) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Exagen Inc   (NASDAQ: XGN)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Exagen Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Exagen Inc's ROI in the second quarter of 2026?
Exagen Inc achieved a return on average invested assets (ROI) of 1.18 % in its second quarter of 2026, this is above XGN's average return on investment of 0%.
Exagen Inc invested over the 12 months ending in its second quarter of 2026 $43 million

ROI decreased relative to the period ending Mar 31 2026, due to the decline in net income.

Within the Healthcare sector Exagen Inc achieved the highest return on investment. While the total ranking for ROI remained the same, compared to the first quarter of 2026 at no. .

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 21.94 % 37.44 % 13.97 % -3.63 % -20.8 %
Y / Y Net Income Change TTM -79.96 % - - - -
Investment (TTM) in Millions 38 39 44 50 48
Return On Investment (TTM) 1.18 % 8.07 % -0.12 % 19.38 % 7.17 %
XGN's Overall Ranking # # # # #
Seq. Investment Change TTM -5.5 % 7.77 % 8.13 % 10.73 % 6.51 %
Seq. Net Income Change TTM -86.19 % - - 199.09 % -
Net Income (TTM) in Millions 1 4 0 8 3

XGN Company Profile >> Back to XGN Roi Comparisons >> See Annual XGN Return On Investment



Return On Investment XGN's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Exagen Inc's II. Quarter Investments $ 38 Millions XGN's Balance sheet
Exagen Inc's II. Quarter Income $ -3 Millions Quarterly XGN's Income Statement
XGN's Income by Division See XGN's Income by Division


XGN Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 44 31 45 77 114
Y / Y Investment Growth 40.66 % -30.77 % -41.2 % -32.7 % 63.9 %
Net Income in Millions 0 0 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -0.12 % -0.04 % -0.07 % 0.37 % -0.15 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
XGN's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for XGN's Competitors
Subscribers only: Roi for Exagen Inc's Suppliers
Subscribers only: Return On Investment for XGN's Customers

Other Ratios
XGN's Roa XGN's Inventory Turnover Ratio XGN's Growth Rates XGN's Dividend Statistics
XGN's Profitability Ratios XGN's Asset Turnover Ratio XGN's Dividend Growth
XGN's Roe XGN's Valuation Ratios XGN's Financial Strength Ratios XGN's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Merck and Co Inc   3.24 %
Community Health Systems Inc   3.12 %
National Vision Holdings Inc   2.99 %
Teva Pharmaceutical Industries Limited  2.66 %
Lifestance Health Group Inc   2.61 %
Conmed Corporation  2.57 %
Pfizer Inc  2.53 %
Mimedx Group Inc   2.38 %
Bio rad Laboratories Inc   2.34 %
Lifemd Inc   2.32 %
Alkermes Plc   2.31 %
Becton Dickinson And Company  2.22 %
Revvity Inc  2.18 %
Envista Holdings Corporation  2.06 %
Immucell Corporation  1.95 %
Atricure Inc   1.84 %
Black Hawk Acquisition Corporation  1.79 %
Omada Health Inc   1.70 %
Arvinas Inc   1.53 %
Repligen Corp  1.41 %
Cormedix Inc   1.31 %
Pacira Biosciences inc   1.29 %
Waters Corporation  1.20 %
Surgery Partners Inc   1.02 %
Warby Parker Inc   0.98 %
Staar Surgical Co  0.98 %
Biomarin Pharmaceutical Inc  0.91 %
Icu Medical Inc  0.87 %
Radnet Inc   0.45 %
Delcath Systems Inc   0.45 %

Date modified: 2026-09-26T07:36:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.